Our latest news

Source BioScience to offer Fluidigm SNP genotyping service

26 November 2009

For More Information

Source BioScience provides Interim Management Statement

17 November 2009

The Company today provides its Interim Management Statement as required by the UK Listing Authority's Disclosure and Transparency Rules, relating to the period from 1 July 2009 to 17 November 2009.

For More Information

Interim Results

25 August 2009

The Company today announced its interim results for the six months ended 30 June 2009.

For More Information

Source BioScience extends agreement with Cervical Screening Wales

23 July 2009

The Company is pleased to announce an extension to the existing agreement to supply cytology services and automated imaging technology to Cervical Screening Wales.

For More Information

Result of Annual General Meeting

04 June 2009

Source BioScience confirms that all resolutions put to the Annual General Meeting held on 4th June 2009 were duly passed by Shareholders.

Details of proxy voting on the resolutions put to Shareholders at the Annual General Meeting are available on the Company's website - www.sourcebioscience.com.

At the AGM the Chairman, Laurie Turnbull, delivered his annual statement, details of which are contained under 'More information'.

For More Information

Attendance at ICR Centennial and ERBI Annual Conferences

27 May 2009

Dr Jackie Rodgers, Head of Business Development, Pharma Biotech Worldwide for Source BioScience, the Nottingham, UK based healthcare and biotechnology company, will be attending a couple of key conferences in the coming weeks, to discuss partnering opportunities with pharmaceutical and biotech companies. The first of these will be the ICR Centennial Conference at the Queen Elizabeth Centre in London, 8th-9th June, followed by the ERBI Annual Conference in Cambridge, 10th-12th June. The expertise offered by Source BioScience supports clinical trials with contract research services, assisting biomarker discovery and validation, pharmacogenomics and companion diagnostics. Dr Rodgers will also be evaluating opportunities for in-licensing and developing reference laboratory services for novel diagnostic, prognostic and predictive tests.

Dr Rodgers would be pleased to meet with companies wishing to discuss how Source BioScience could be of assistance in the areas of expertise outlined. Please contact her via email - jackie.rodgers@sourcebioscience.com.